SCHEMBL5378588

SCHEMBL5378588

COC(=O)c1cc(S(=O)(=O)N(c2ccc(OC(F)(F)F)cc2)c2ccc3ocnc3c2)ccc1C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.38
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
P2RY2 P41231 1/20 0.35
P2RY1 P47900 1/20 0.35
P2RY14 Q15391 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP2C9 P11712 1/20 0.33
CFTR P13569 1/20 0.33
TSHR P16473 1/20 0.33
KDR P35968 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
CCR9 P51686 1/20 0.33
NAMPT P43490 1/20 0.33
HCRTR2 O43614 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378792 0.93 TRPM8 (0.43) TRPM8ALDH1A1KDM4EPKMSMN1; SMN2
SCHEMBL5382107 0.89 SMN1; SMN2 (0.35) TRPM8ALDH1A1KDM4EPKMSMN1; SMN2
SCHEMBL5921895 0.88 TP53 (0.38) ALDH1A1KDM4EP2RY1SMN1; SMN2LMNA
SCHEMBL5376744 0.88 ALDH1A1 (0.38) TRPM8ALDH1A1KDM4EPKMSMN1; SMN2
SCHEMBL5371938 0.83 TRPM8 (0.39) TRPM8HCRTR2
SCHEMBL5368704 0.82 TRPM8 (0.41) TRPM8ALDH1A1KDM4EPKMHCRTR2
SCHEMBL5367888 0.80 GAA (0.37) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL5376611 0.79 SMN1; SMN2 (0.34) ALDH1A1SMN1; SMN2NPC1RAB9ATP53
SCHEMBL5376782 0.78 GAA (0.36) ALDH1A1PKMSMN1; SMN2LMNACFTR
SCHEMBL5921908 0.77 TP53 (0.39) ALDH1A1SMN1; SMN2NPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TRPM8 4317/4885ALDH1A1 2956/4885KDM4E 3834/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD TRPM8 4175/4885ALDH1A1 2752/4885KDM4E 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.